RNA Outsourcing Videos

1. ICH E6(R3): Practical Steps For Implementation 12/14/2023

   Watch this presentation to equip stakeholders with actionable strategies and a comprehensive understanding of the evolving clinical trial management landscape in the context of ICH guidelines.

2. Scale-Up And Production Of Key Lipids Used In mRNA Delivery Systems 2/13/2025

   Discover key strategies for overcoming challenges in the industrial-scale production of ionizable and PEG lipids to optimize mRNA vaccine formulation and address critical manufacturing requirements.

3. Validation Of mRNA Concentration Determination 8/20/2023

   mRNA-based therapeutics require comprehensive analytical testing to meet regulatory requirements. Optimize processes and ensure fast and reliable results as you bring your product to market.

4. Regulatory Confidence, Manufacturing Excellence 10/20/2025

   With decades of experience, we offer a flexible and collaborative partnership model for manufacturing excellence that enables our clients to increase speed to market with full regulatory confidence.

5. Customized mRNA Processing For Improved Therapy Development And Manufacturing 2/13/2025

   Optimize mRNA development by learning key strategies for process refinement, critical component identification, and in-process analytics to enhance therapeutic production.

6. Our Experience Creates Reliable Results 6/27/2024

   Hear from inSeption Group clients as they share their experiences, recount their journeys and highlight the exceptional service and support they received.

7. An Early Formulation Screening Service 5/23/2024

   Gain insights into overcoming the challenges in lipid nanoparticle (LNP) formulation, explore critical aspects of the process and analytical development of LNPs, and much more.

8. Addressing Industry Challenges In mRNA Product Commercialization

   While the speed of production and flexibility of mRNA are appealing, several industry challenges must still be addressed to realize the full potential and further expand its use.

9. Don't Forget These Important Points When Selecting An RNA CDMO 8/22/2024

   Together, Omega’s Jeff Atkinson & Sail Biomedicines’ Jim Nolan share their perspectives on the health of the linear mRNA and circRNA outsourcing sector.

10. How Can Sponsors & CDMOs Collaborate On RNA Analytical/Process Development? 8/22/2024

    Having worked on both the innovator and CDMO sides of the industry, Advancing RNA LIVE panelist Khaled Yamout outlines where he sees the greatest weaknesses in these critical sponsor-CDMO partnerships and offers guidance.